Status Epilepticus Management
1. Definition (ILAE 2015)
- Operational Definition (Time
): A seizure lasting > 5 minutes or recurrent seizures without return of consciousness between events. Treatment should begin immediately at this point. - Tissue Injury Threshold (Time
): A seizure lasting > 30 minutes. Risk of long-term neuronal injury and pharmacoresistance increases significantly.
2. General Principles (ABCDE)
- Airway: Position head, suction secretions, consider intubation if GCS < 8 or airway compromised.
- Breathing: High-flow oxygen (100%). Monitor SpO2 and EtCO2.
- Circulation: Establish 2 large-bore IV lines. Monitor BP and ECG.
- Dextrose: Bedside glucometry. If Hypoglycemia (<60 mg/dL): Give Dextrose 10% (2β5 mL/kg) or D25 (2 mL/kg).
- Electrolytes: Send samples for Na+, Ca++, Mg++, AED levels, ABG, Toxicology.
3. Stepwise Management Algorithm (Time-Based)
Phase I: Stabilization (0 β 5 Minutes)
- Start timing the seizure.
- Stabilize Airway, Breathing, Circulation.
- Check Glucose. Treat hypoglycemia if present.
- Attempt IV access. (Do not delay first-line treatment > 5 mins for IV access; use IO or IM/Intranasal/Buccal).
Phase II: Initial Therapy / Early Status (5 β 20 Minutes)
- Goal: Stop seizure using Benzodiazepines.
- First-Line Agent (Choose ONE):
- IV Lorazepam: 0.1 mg/kg (Max 4 mg). (Gold Standard)
- IV Diazepam: 0.2β0.3 mg/kg (Max 10 mg).
- IM Midazolam: 0.2 mg/kg (Max 10 mg). (If no IV access).
- If seizure continues after 5 minutes:
- Repeat the chosen benzodiazepine dose ONCE.
- Do not exceed 2 doses (risk of respiratory depression).
Phase III: Second Therapy / Established Status (20 β 40 Minutes)
- Goal: Initiate long-acting anti-seizure medication (ASMs) immediately if benzodiazepines fail.
- Drugs of Choice (ESETT Trial showed equal efficacy for Fosphenytoin, Valproate, Levetiracetam):
- IV Fosphenytoin: 20 mg PE/kg. (Rate: 150 mg PE/min). Preferred over Phenytoin (less hypotension/tissue necrosis).
- IV Valproate (Sodium Valproate): 20β40 mg/kg. (Rate: 3β6 mg/kg/min). Avoid in suspected metabolic/liver disease.
- IV Levetiracetam: 40β60 mg/kg (Max 4500 mg). (Infuse over 15 mins).
- IV Phenobarbital: 20 mg/kg. (Rate: 1 mg/kg/min). Consider if others unavailable or in febrile status.
- Support: Monitor for hypotension and arrhythmias during infusion.
Phase IV: Third Therapy / Refractory Status (40 β 60 Minutes)
- Definition: Seizure persists despite adequate Benzodiazepine + One Second-line ASM.
- Action:
- Rapid Sequence Intubation (RSI) and mechanical ventilation.
- Continuous EEG monitoring (cEEG) is mandatory.
- Initiate Continuous IV Anesthetic Infusion.
| Agent | Loading Dose | Maintenance Infusion | Remarks |
|---|---|---|---|
| Midazolam | 0.2 mg/kg bolus | 1β5 mcg/kg/min (Titrate up q15min) | Preferred in children. Less hemodynamic instability. Tachyphylaxis occurs. |
| Pentobarbital / Thiopental | 3β5 mg/kg bolus | 1β5 mg/kg/hr | Effective but causes severe hypotension/myocardial depression. Requires vasopressors. |
| Propofol | 1β2 mg/kg bolus | 1β5 mg/kg/hr | Caution: Risk of Propofol Infusion Syndrome (PRIS) in children with high doses >48hrs. Generally avoided in young children if alternatives exist. |
| Ketamine | 1β2 mg/kg bolus | 10β50 mcg/kg/min | NMDA antagonist. Neuroprotective. Good for hemodynamic stability. |
Phase V: Super-Refractory Status (> 24 Hours)
- Definition: SE continues > 24 hours despite anesthetics, or recurs on weaning.
- Therapies:
- Ketogenic Diet (4:1 ratio via NG tube).
- Immunotherapy (IVIG, Methylprednisolone, Plasma Exchange) β Assume autoimmune/inflammatory cause (NORSE).
- Inhalational Anesthetics (Isoflurane).
- Vagus Nerve Stimulation (VNS).
- Hypothermia (Therapeutic hypothermia 32β35Β°C).
4. Summary Table of Pediatric Doses
| Drug | Dose | Max Dose | Rate |
|---|---|---|---|
| Lorazepam | 0.1 mg/kg IV | 4 mg | 2 mg/min |
| Midazolam | 0.2 mg/kg IM/IN/Buccal | 10 mg | Bolus |
| Diazepam | 0.2β0.3 mg/kg IV | 10 mg | 2 mg/min |
| Fosphenytoin | 20 mg PE/kg IV | 1500 mg PE | 150 mg/min |
| Valproate | 20β40 mg/kg IV | 3000 mg | 6 mg/kg/min |
| Levetiracetam | 40β60 mg/kg IV | 4500 mg | 15 mins |
| Phenobarbital | 20 mg/kg IV | 1000 mg | 30 mg/min |
5. Investigations (Concurrent with Management)
- Immediate: Glucose, Electrolytes (Na, Ca, Mg), ABG.
- Urgent: AED levels (if known epileptic), CBC, Renal/Liver function.
- If Indicated: Neuroimaging (CT/MRI) after stabilization. Lumbar Puncture (if fever/meningeal signs present and ICP normal).